Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Declines By 31.2%

Aditxt, Inc. (NASDAQ:ADTX) was the target of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 86,655 shares, a decline of 31.2% from the November 30th total of 125,952 shares. Approximately 11.9% of the company’s shares are short sold. Based on an average daily volume of 940,286 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 940,286 shares, the short-interest ratio is currently 0.1 days. Approximately 11.9% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Aditxt Price Performance

ADTX opened at $1.12 on Monday. Aditxt has a one year low of $1.05 and a one year high of $6,412.75. The business has a 50 day simple moving average of $7.18 and a two-hundred day simple moving average of $79.79. The firm has a market capitalization of $817,600.00, a price-to-earnings ratio of 0.00 and a beta of 1.43.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.